Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis

Meta-analysis (15 studies;n=10,659) found no significant reduction in mortality, time to fever resolution or clinical deterioration/development of ARDS with hydroxychloroquine (HCQ) use; and there was a higher risk of ECG abnormalities/arrhythmia with HCQ/chloroquine.

Journal of General Internal Medicine